» Articles » PMID: 37221419

Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study

Overview
Journal Rheumatol Ther
Date 2023 May 23
PMID 37221419
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Systemic sclerosis (SSc) and idiopathic inflammatory myopathies (IIM) are very rare rheumatic diseases burdened by a high prevalence of sexual dysfunctions. However, no specific treatment has been proposed to date. To our knowledge, this is the first (pilot) study aiming to investigate the effect of an 8-week tailored physiotherapy program on the sexual health of women with SSc and IIM.

Methods: In total, 12 women with SSc and 4 women with IIM were enrolled in the study. Based on the patients' capability to participate in the program, they were divided into an intervention group (IG) (mean ± SD age 46.8 ± 8.6 years) and a control group (CG) (mean ± SD age 46.3 ± 8.5 years). IG underwent the 8-week program (1 h of supervised physiotherapy twice weekly), whereas CG received no physiotherapy. At weeks 0 and 8, all patients filled in questionnaires assessing sexual function (Female Sexual Function Index [FSFI], Brief Index of Sexual Functioning for Women [BISF-W]), sexual quality of life (Sexual Quality of Life-Female [SQoL-F]), functional ability (Health Assessment Questionnaire [HAQ]), quality of life (Medical Outcomes Short Form-36 [SF-36]), and depression (Beck's Depression Inventory-II [BDI-II]). The changes were analyzed with two-way ANOVA and Friedmann's test.

Results: Compared to the statistically significant deterioration in CG over weeks 0-8, we found statistically significant improvements in the total scores of FSFI and BISF-W, and some of their domains, functional status, and the physical component of quality of life.

Conclusion: Our 8-week physiotherapy program not only prevented the natural course of progressive deterioration of functional ability but also led to a significant improvement in sexual function and quality of life in women with SSc and IIM. However, due to the lack of randomization and a relatively small sample size resulting from the strict inclusion criteria, further validation of our results is needed.

Trial Registration Number: ISRCTN91200867 (prospectively registered).

Citing Articles

Assessing the effectiveness of measurement scales in evaluating the health-related quality of life in rare disease patients after treatment: a systematic review.

Dumbuya J, Ahmad B, Zeng C, Chen X, Lu J Health Qual Life Outcomes. 2024; 22(1):108.

PMID: 39696506 PMC: 11657302. DOI: 10.1186/s12955-024-02324-0.

References
1.
Denton C, Khanna D . Systemic sclerosis. Lancet. 2017; 390(10103):1685-1699. DOI: 10.1016/S0140-6736(17)30933-9. View

2.
Vencovsky J, Alexanderson H, Lundberg I . Idiopathic Inflammatory Myopathies. Rheum Dis Clin North Am. 2019; 45(4):569-581. DOI: 10.1016/j.rdc.2019.07.006. View

3.
Almeida C, Almeida I, Vasconcelos C . Quality of life in systemic sclerosis. Autoimmun Rev. 2015; 14(12):1087-96. DOI: 10.1016/j.autrev.2015.07.012. View

4.
Feldon M, Noroozi Farhadi P, Brunner H, Itert L, Goldberg B, Faiq A . Predictors of Reduced Health-Related Quality of Life in Adult Patients With Idiopathic Inflammatory Myopathies. Arthritis Care Res (Hoboken). 2017; 69(11):1743-1750. PMC: 5524619. DOI: 10.1002/acr.23198. View

5.
Hermankova B, Spiritovic M, Oreska S, Storkanova H, Komarc M, Klein M . Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study. Rheumatology (Oxford). 2021; 60(11):5060-5072. PMC: 8566285. DOI: 10.1093/rheumatology/keab397. View